Tower Research Capital LLC (Trc) Crispr Therapeutics Ag Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 64,946 shares of CRSP stock, worth $3.59 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
64,946
Previous 22,469 189.05%
Holding current value
$3.59 Million
Previous $1.09 Million 285.44%
% of portfolio
0.12%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$48.51 - $68.14 $2.06 Million - $2.89 Million
42,477 Added 189.05%
64,946 $4.21 Million
Q2 2025

Aug 14, 2025
SELL
$31.27 - $48.64 $58,975 - $91,735
-1,886 Reduced 7.74%
22,469 $1.09 Million
Q1 2025

May 15, 2025
BUY
$34.03 - $53.02 $643,235 - $1 Million
18,902 Added 346.63%
24,355 $828,000
Q4 2024

Feb 13, 2025
BUY
$38.65 - $55.15 $175,625 - $250,601
4,544 Added 499.89%
5,453 $214,000
Q3 2024

Nov 14, 2024
SELL
$44.62 - $62.75 $79,155 - $111,318
-1,774 Reduced 66.12%
909 $42,000
Q2 2024

Aug 13, 2024
SELL
$51.17 - $68.18 $89,496 - $119,246
-1,749 Reduced 39.46%
2,683 $144,000
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $61,640 - $90,545
1,016 Added 29.74%
4,432 $302,000
Q4 2023

Feb 13, 2024
SELL
$38.62 - $72.18 $33,020 - $61,713
-855 Reduced 20.02%
3,416 $213,000
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $428,481 - $556,960
-9,440 Reduced 68.85%
4,271 $193,000
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $213,176 - $332,344
-4,904 Reduced 26.34%
13,711 $769,000
Q1 2023

May 09, 2023
BUY
$41.0 - $56.12 $623,979 - $854,090
15,219 Added 448.14%
18,615 $842,000
Q4 2022

Feb 10, 2023
SELL
$39.19 - $65.67 $924,648 - $1.55 Million
-23,594 Reduced 87.42%
3,396 $138,000
Q3 2022

Nov 10, 2022
BUY
$61.1 - $83.78 $557,720 - $764,743
9,128 Added 51.1%
26,990 $1.76 Million
Q2 2022

Aug 15, 2022
BUY
$43.23 - $73.83 $488,153 - $833,688
11,292 Added 171.87%
17,862 $1.09 Million
Q1 2022

May 12, 2022
BUY
$53.19 - $79.24 $185,367 - $276,151
3,485 Added 112.97%
6,570 $413,000
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $12,125 - $19,253
173 Added 5.94%
3,085 $234,000
Q3 2021

Nov 15, 2021
SELL
$110.2 - $156.64 $1.01 Million - $1.43 Million
-9,149 Reduced 75.86%
2,912 $326,000
Q2 2021

Aug 16, 2021
SELL
$100.84 - $161.89 $3.38 Million - $5.42 Million
-33,509 Reduced 73.53%
12,061 $1.95 Million
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $4.68 Million - $8.88 Million
42,265 Added 1278.82%
45,570 $5.55 Million
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $216,463 - $470,665
2,717 Added 462.07%
3,305 $506,000
Q3 2020

Nov 16, 2020
BUY
$78.5 - $100.64 $27,082 - $34,720
345 Added 141.98%
588 $49,000
Q2 2020

Aug 13, 2020
BUY
$38.5 - $76.05 $9,355 - $18,480
243 New
243 $18,000
Q1 2020

May 15, 2020
SELL
$33.68 - $62.53 $34,218 - $63,530
-1,016 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$36.68 - $73.13 $35,542 - $70,862
969 Added 2061.7%
1,016 $62,000
Q3 2019

Nov 05, 2019
SELL
$40.99 - $52.56 $9,878 - $12,666
-241 Reduced 83.68%
47 $2,000
Q2 2019

Aug 13, 2019
SELL
$35.45 - $48.2 $30,487 - $41,452
-860 Reduced 74.91%
288 $14,000
Q1 2019

May 14, 2019
SELL
$28.02 - $40.87 $878,539 - $1.28 Million
-31,354 Reduced 96.47%
1,148 $41,000
Q4 2018

Feb 14, 2019
BUY
$22.73 - $42.34 $705,243 - $1.31 Million
31,027 Added 2103.53%
32,502 $929,000
Q3 2018

Nov 13, 2018
BUY
$44.35 - $65.71 $36,455 - $54,013
822 Added 125.88%
1,475 $65,000
Q2 2018

Aug 15, 2018
SELL
$42.62 - $73.59 $80,082 - $138,275
-1,879 Reduced 74.21%
653 $38,000
Q1 2018

May 15, 2018
BUY
$23.52 - $58.17 $59,552 - $147,286
2,532 New
2,532 $116,000
Q4 2017

Feb 09, 2018
SELL
$16.95 - $23.48 $23,509 - $32,566
-1,387 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$16.75 - $20.66 $23,232 - $28,655
1,387
1,387 $25,000

Others Institutions Holding CRSP

# of Institutions
545
Shares Held
67.7M
Call Options Held
3.5M
Put Options Held
3.08M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.32B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email